Read More Pharma Industry News Chemomab Therapeutics (CMMB) and Scipher Medicine to merge in $150m reverse deal Scipher Medicine and Chemomab are merging in all-stock deal, taking Scipher public via reverse merger. $30M PIPE led by Northpond. Q4 2026 close, H1 2028 Phase 2 data. byVenkateshJuly 8, 2026